tiprankstipranks
Anavex Life Sciences (AVXL)
NASDAQ:AVXL
US Market
Holding AVXL?
Track your performance easily

Anavex Life Sciences (AVXL) Financial Statements

1,554 Followers

Anavex Life Sciences Financial Overview

Anavex Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.514; its P/E ratio is ―; Anavex Life Sciences is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -16.85M$ -14.08M$ -12.67M$ -11.29M$ -10.21M
EBITDA$ -16.85M$ -14.08M$ -12.67M$ -11.29M$ -10.21M
Net Income Common Stockholders$ -11.09M$ -12.74M$ -10.55M$ -8.62M$ -10.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 132.19M$ 138.76M$ 139.39M$ 143.76M$ 151.02M
Total Assets$ 135.57M$ 141.53M$ 144.52M$ 148.07M$ 154.39M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 15.30M$ 11.66M$ 9.56M$ 12.49M$ 12.53M
Stockholders Equity$ 120.26M$ 129.87M$ 134.96M$ 135.57M$ 141.85M
Cash Flow-
Free Cash Flow$ -6.66M$ -5.18M$ -11.66M$ -7.32M$ -5.85M
Operating Cash Flow$ -6.66M$ -5.18M$ -11.66M$ -7.32M$ -5.85M
Investing Cash Flow-----
Financing Cash Flow$ 89.00K$ 4.55M$ 7.28M$ 59.00K$ 2.06M
Currency in USD

Anavex Life Sciences Earnings and Revenue History

Anavex Life Sciences Debt to Assets

Anavex Life Sciences Cash Flow

Anavex Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis